View Post

Jemperli

In Clinical Studies News by Barbara Jacoby

From: breastcancer.org Jemperli (chemical name: dostarlimab-gxly) is approved by the U.S. Food and Drug Administration (FDA) to treat mismatch repair deficient (dMMR) advanced-stage breast cancer that has grown during or after treatment if no other treatment options are available. Jemperli also is approved to treat dMMR advanced-stage endometrial cancer that has grown after treatment with platinum chemotherapy. How Jemperli works …

View Post

Savvy Cooperative: Endometrial Cancer Patients (or their Caregivers) Experienced with the Combination Treatment of Keytruda and Lenvima

In Paid Opportunities For The Cancer Community by Barbara Jacoby

SCREENER Eligibility Criteria: Have been diagnosed with endometrial cancer Proof of diagnosis will be required to participate Participant has experience with combination treatment of Keytruda and Lenvima. US Residents Details: 60-minute to 90-minute interviews Receive: $100-$150 Link: https://gigs.savvy.coop/endometrial/?r=44951 Why Sign Up? Your experiences are so valuable and important to creating better products and services, that companies and researchers will pay …

View Post

Rare Patient Voice: Study Opportunity for Endometrial Cancer Patients

In Paid Opportunities For The Cancer Community by Barbara Jacoby

Study Details: 60 min Web-Assisted Interview followed by a 30-minute survey US patients only Compensation $200 upon completion of both (both must be completed)  Please sign up at the link below for more information or to see if you qualify. http://letlife.in/rare-patient-voice Why Sign up with Rare Patient Voice? Who knows better than you about your journey and experiences?  We connect …

View Post

In first, cancer drugs simultaneously approved in US, Canada, Australia

In In The News by Barbara Jacoby

From: biopharmadive.com For the first time, regulators in the U.S., Australia and Canada on Tuesday simultaneously approved two cancer drugs via a project led by the Food and Drug Administration’s oncology center. Merck & Co.’s immunotherapy Keytruda, when paired with Merck and Eisai’s Lenvima, is now cleared to treat certain endometrial tumors, a decision that expands the labels for both …

View Post

New Guidelines Provide Vital Information for Women Diagnosed with the Most Common Type of Gynecologic Cancer

In In The News by Barbara Jacoby

NCCN Guidelines for Patients: Uterine Cancer — published during Gynecologic Cancer Awareness Month — explains treatment options and raises awareness While the number of deaths from most cancers is on the decline in the United States, it is rising for the most common type of uterine cancer—endometrial cancer. The newest NCCN Guidelines for Patients® focuses on uterine cancers (endometrial cancer …

View Post

ONC201 Trial Begins for Endometrial and Breast Cancer

In In The News by Barbara Jacoby

Oncoceutics, Inc. announced today that the first patient has been treated in a clinical trial of ONC201 for patients with certain types of advanced endometrial and breast cancer. The Phase II trial is led by Alexandra Zimmer, MD, Assistant Research Physician at the Women’s Malignancies Branch at the National Cancer Institute (NCI) Center for Cancer Research, part of the National …

View Post

Increased Endometrial Cancer Rates Found in Women with High Levels of Cadmium

In In The News by Barbara Jacoby

More than 31,000 new cases of endometrial cancer are expected to be diagnosed in 2017. Through a five-year observational study recently published in PLOS One, researchers at the University of Missouri found that women with increased levels of cadmium — a metal commonly found in foods such as kidneys, liver and shellfish as well as tobacco — also had an …

View Post

Using the pill can protect women from certain cancers ‘for up to 30 years’

In In The News by Barbara Jacoby

From: theguardian.com Women who have taken the contraceptive pill are protected from some types of cancer for as long as 30 years after they stopped taking it, according to new research. Those who have used the pill “during their reproductive years” are less likely to have bowel cancer, endometrial cancer or ovarian cancer than women who had never taken it, …

View Post

Genetic tests can help with predicting some cancers, treating others

In In The News by Barbara Jacoby

By: Stacey Federoff From: timesonline.com Rosemary Wargula of Hopewell Township has folders’ worth of papers with information about her last 12 years battling cancer, beginning in 2004. A nurse for more than 40 years before she retired, Wargula, 72, put on red reading glasses held around her neck with a string of beads to read from a small notebook, where …

View Post

Gene ‘Signature’ Could Lead to Early Cancer Test

In In The News by Barbara Jacoby

By: Maggie Fox From: nbcnews.com Researchers have found a genetic “signature” common to five different types of cancer and hope it might be a step towards an early blood test for cancer in general. It’s not a genetic mutation but a change in the genetic function called methylation, the team at the National Human Genome Research Institute, one of the …